Previously, we established that 25-50% depletion of CCT2 caused loss of viability in MDA-MB-231 breast cancer cells and could inhibit tumor growth in a syngeneic mouse model of E0771 TNBC cells (40). Here, CCT2 is linked to neoplasm.